Weekly Q&A: Oveporexton

Join me for my Weekly Mental Health Recap and Q&A! Livestream every Tuesday at 9:00am West Coast USA / 12:00pm East Coast USA / 6:00am Hawaii / 6:00pm Central European Video released this week: - Oveporexton - The First Orexin Receptor Activator https://youtu.be/qUu76gKkBTk After a 1 minute recap of the video, I’ll be available for questions on this topic or any other related to Mental Health. - Oveporexton - The First Orexin Receptor Activator: Takeda Pharmaceutical's oveporexton is likely to be approved in 2026 as the first orexin receptor agonist. Although the application is only for its use in narcolepsy, it is likely that oveporexton will also be used off label to address a variety of problems with feeling sedated/fatigued/unfocused - and that includes ADHD. ----- You can also discuss and ask questions on my Reddit page: https://www.reddit.com/r/Drjohnkruse Follow https://dockruse.medium.com on Medium for hundreds of full length articles on this subject and more! Access to full articles requires paid membership. ----- Psychiatrist, neuroscientist, and author John Kruse, MD, PhD presents practical, actionable, well-researched information about treatment options that scientists and clinicians recommend for adult ADHD and other mental health conditions. Subscribe if you're curious about how neuroatypical brains can optimize their functioning in our shared, and somewhat strange, world. ADHD topics have a pink background, and those on more general mental health topics have a purple background. A small collection of Politics related videos have an orange background. Dr. Kruse has posted videos in the "Videos", "Live", and "Shorts", sections of this channel. You're welcome to email him with topics you want discussed or people you think he should interview. [email protected] #health #mentalhealth #adhd